2008
DOI: 10.1158/1055-9965.epi-07-2538
|View full text |Cite
|
Sign up to set email alerts
|

An Object Lesson: Source Determines the Relations That Trait Anxiety, Prostate Cancer Worry, and Screening Fear Hold with Prostate Screening Frequency

Abstract: Fears regarding prostate cancer and the associated screening are widespread. However, the relations between anxiety, cancer worry, and screening fear and screening behavior are complex, because anxieties stemming from different sources have different effects on behavior. In differentiating among anxieties from different sources (trait anxiety, cancer worry, and screening fear), we expected that cancer worry would be associated with more frequent screening, whereas fear of screening would be associated with les… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
84
2
1

Year Published

2012
2012
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(94 citation statements)
references
References 69 publications
6
84
2
1
Order By: Relevance
“…Its impact on cancer screening in men [15] and on PSA testing has received little attention, however, and results have been conflicting due to small sample sizes and different measures used [16-18]. In addition, a small number of studies have recently reported that markers of healthcare utilisation influenced whether men have PSA tests and other cancer screening [17,19,20].…”
Section: Introductionmentioning
confidence: 99%
“…Its impact on cancer screening in men [15] and on PSA testing has received little attention, however, and results have been conflicting due to small sample sizes and different measures used [16-18]. In addition, a small number of studies have recently reported that markers of healthcare utilisation influenced whether men have PSA tests and other cancer screening [17,19,20].…”
Section: Introductionmentioning
confidence: 99%
“…Although disease-related worry tends to be low to moderate in the general population for diseases such as cancer (Hay et al, 2005), it may play a larger role in risk response among individuals of low socioeconomic status, who may feel more vulnerable because they lack the time and resources to effectively manage risks. Lower income and less education are related to greater worry across a variety of health risks (Beckjord, Rutten, Arora, Moser, & Hesse, 2008;Consedine, Adjei, Ramirez, & McKiernan, 2008;Sjoberg, 1998). Among people of lower socioeconomic status, worry was shown to affect the health protective behaviors of Blacks but not Whites (Ransford, 1986) and was also related to not having health insurance, to less discussion with physicians, and to greater perceived barriers to use of the health care system (Consedine et al, 2008).…”
Section: Cognitive and Emotional Dimensions Of Riskmentioning
confidence: 99%
“…Lower income and less education are related to greater worry across a variety of health risks (Beckjord, Rutten, Arora, Moser, & Hesse, 2008;Consedine, Adjei, Ramirez, & McKiernan, 2008;Sjoberg, 1998). Among people of lower socioeconomic status, worry was shown to affect the health protective behaviors of Blacks but not Whites (Ransford, 1986) and was also related to not having health insurance, to less discussion with physicians, and to greater perceived barriers to use of the health care system (Consedine et al, 2008). In contrast, people living in poverty may exhibit a fatalism that alleviates worry if they feel there is little they can do to prevent these health risks (Niederdeppe & Levy, 2007).…”
Section: Cognitive and Emotional Dimensions Of Riskmentioning
confidence: 99%
“…Se considera que la ansiedad es adaptativa si es proporcional a la amenaza, es transitoria, solo dura mientras persiste el estímulo temido y si facilita la puesta en marcha de recursos. Sin embargo, se considera desadaptativa cuando es desproporcionada a la amenaza, implica un aumento anómalo de la frecuencia, intensidad o duración de los síntomas y se mantiene en el tiempo (6,7) . La presencia de ansiedad ha sido documentada a lo largo del tratamiento oncoló-gico, en el diagnóstico (8)(9)(10) , recidiva, cuando el paciente está esperando el tratamiento (1,11) así como en estadios avanzados (10) .…”
Section: Introductionunclassified